Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
35.66B | 44.43B | 44.52B | 57.82B | 35.05B | 46.64B | Gross Profit |
13.84B | 18.57B | 16.28B | 17.69B | 15.36B | 15.09B | EBIT |
9.82B | 13.02B | 10.78B | 12.62B | 11.23B | 10.90B | EBITDA |
15.40B | 18.81B | 16.45B | 18.03B | 16.31B | 15.72B | Net Income Common Stockholders |
5.78B | 8.45B | 9.14B | 8.71B | 7.12B | 7.05B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
19.42B | 28.42B | 27.91B | 28.23B | 29.70B | 28.77B | Total Assets |
402.35B | 405.98B | 398.33B | 376.21B | 381.35B | 339.55B | Total Debt |
233.43B | 222.67B | 222.04B | 202.24B | 211.73B | 182.98B | Net Debt |
214.66B | 202.26B | 201.14B | 179.03B | 182.04B | 167.21B | Total Liabilities |
288.25B | 280.33B | 279.01B | 256.93B | 262.71B | 232.25B | Stockholders Equity |
114.11B | 125.65B | 119.32B | 119.28B | 118.64B | 107.30B |
Cash Flow | Free Cash Flow | ||||
0.00 | 1.32B | -16.66B | 13.81B | -22.83B | 16.88B | Operating Cash Flow |
0.00 | 19.58B | 23.95B | 34.19B | 8.29B | 28.68B | Investing Cash Flow |
0.00 | -19.36B | -40.25B | -20.70B | -30.20B | -11.43B | Financing Cash Flow |
0.00 | 280.00M | 13.99B | -15.49B | 24.33B | -1.83B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | $3.92T | 19.52 | 6.51% | 2.00% | 0.83% | -6.10% | |
72 Outperform | $715.65B | 10.10 | 9.23% | 3.18% | 6.15% | 12.10% | |
69 Neutral | ¥527.77B | 8.03 | 12.46% | 3.47% | 23.35% | 46.19% | |
68 Neutral | $3.00T | 15.61 | 8.35% | 1.63% | 16.32% | 43.72% | |
68 Neutral | $2.56T | 14.24 | 8.41% | 1.23% | 5.85% | 3.72% | |
59 Neutral | $2.73B | 11.65 | 0.11% | 8783.19% | 5.45% | -17.32% | |
59 Neutral | €174.11B | 28.44 | 4.72% | 2.96% | -25.86% | -45.61% |